---
title: Effect of Vitamin D in Burn Patients
nct_id: NCT03884036
overall_status: UNKNOWN
phase: NA
sponsor: Hangang Sacred Heart Hospital
study_type: INTERVENTIONAL
primary_condition: Burn Surgery
countries: South Korea
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT03884036.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT03884036"
ct_last_update_post_date: 2019-08-09
last_seen_at: "2026-05-12T06:33:33.685Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# Effect of Vitamin D in Burn Patients

**Official Title:** Effect of Vitamin D in Burn Patients: A Randomized Clinical Trial

**NCT ID:** [NCT03884036](https://clinicaltrials.gov/study/NCT03884036)

## Key Facts

- **Status:** UNKNOWN
- **Phase:** NA
- **Study Type:** INTERVENTIONAL
- **Target Enrollment:** 264
- **Lead Sponsor:** Hangang Sacred Heart Hospital
- **Collaborators:** Asan Medical Center
- **Conditions:** Burn Surgery
- **Start Date:** 2019-07-18
- **Completion Date:** 2019-10
- **CT.gov Last Update:** 2019-08-09

## Brief Summary

The purpose of this study is to evaluate pre-operative vitamin D levels in patients with burn injuries and evaluate the effect of vitamin D on postoperative complications and duration of hospitalization.

## Detailed Description

Vitamin D deficiency often occurs in burn patients, which may include longer hospitalization and respiratory and cardiac complications.

The purpose of this study is to evaluate pre-operative vitamin D levels in patients with burn injuries and evaluate the effect of vitamin D on postoperative complications and duration of hospitalization.

## Eligibility

- **Minimum age:** 18 Years
- **Sex:** ALL
- **Healthy Volunteers:** No

```
Inclusion Criteria:

* vitamin D \<30 ng/ml
* patients undergoing burn surgery

Exclusion Criteria:

* age \< 18 years old
* hypercalcemia
* renal disease
* cardiac disease ( EF\<40%, MI, angina)
* respiratory disease (ARDS, pneumonia)
* intubated patients
* electrical burn
```

## Arms

- **Vitamin D group** (ACTIVE_COMPARATOR) — Vitamin D 200,000 IU (1 cc) IM
- **Control group** (PLACEBO_COMPARATOR) — Normal saline 1 cc IM

## Interventions

- **Vitamin D** (BIOLOGICAL) — Vitamine D

## Primary Outcomes

- **Incidence of postoperative complications** _(time frame: Within postoperative 1 month)_ — Infection, cardiovascular complication, gastrointestinal complication, respiratory complication, renal complication, and death

## Secondary Outcomes

- **Vitamin D level** _(time frame: Within postoperative 14 days)_

## Locations (1)

- Hangang Sacred Heart Hospital, Seoul, South Korea — _RECRUITING_

## Recent Field Changes (last 30 days)

- `status.overallStatus` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.phases` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.minAge` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `outcomes.secondary` — added _(2026-05-12)_
- `armsInterventions.arms` — added _(2026-05-12)_
- `armsInterventions.interventions` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `sponsor.collaborators` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_
- `locations.hangang sacred heart hospital|seoul||south korea` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT03884036.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT03884036*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*